Dr. Tobias Walbert, MD, PhD, MPH
Claim this profileHenry Ford Hospital
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
17 drugs studied
Area of expertise
1Glioblastoma
MGMT positive
MGMT negative
p53 positive
2Brain Tumor
MET positive
MET negative
Stage III
Affiliated Hospitals
Clinical Trials Tobias Walbert, MD, PhD, MPH is currently running
Gene Therapy + Radiotherapy
for Brain Tumor
The primary goal of this Phase I study is to determine the maximum tolerated dose of oncolytic adenovirus mediated double suicide-gene therapy in combination with fractionated stereotactic radiosurgery in patients with recurrent high-grade astrocytoma undergoing resection.
Recruiting1 award Phase 1
Eflornithine + Temozolomide
for Glioblastoma
The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma is newly diagnosed, and to evaluate safety and tolerability of this combination at that dose.
Recruiting1 award Phase 1
More about Tobias Walbert, MD, PhD, MPH
Clinical Trial Related5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Tobias Walbert, MD, PhD, MPH has experience with
- Temozolomide
- Navtemadlin
- Mirdametinib (PD-0325901)
- Eflornithine
- OKN-007
- Ad5-yCD/mutTKSR39rep-ADP Adenovirus
Breakdown of trials Tobias Walbert, MD, PhD, MPH has run
Glioblastoma
Brain Tumor
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tobias Walbert, MD, PhD, MPH specialize in?
Tobias Walbert, MD, PhD, MPH focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MGMT positive patients, or patients who are MGMT negative.
Is Tobias Walbert, MD, PhD, MPH currently recruiting for clinical trials?
Yes, Tobias Walbert, MD, PhD, MPH is currently recruiting for 2 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Tobias Walbert, MD, PhD, MPH has studied deeply?
Yes, Tobias Walbert, MD, PhD, MPH has studied treatments such as Temozolomide, Navtemadlin, Mirdametinib (PD-0325901).
What is the best way to schedule an appointment with Tobias Walbert, MD, PhD, MPH?
Apply for one of the trials that Tobias Walbert, MD, PhD, MPH is conducting.
What is the office address of Tobias Walbert, MD, PhD, MPH?
The office of Tobias Walbert, MD, PhD, MPH is located at: Henry Ford Hospital, Detroit, Michigan 48202 United States. This is the address for their practice at the Henry Ford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.